LP3 Network Free Webinar - Veterinary Compounding, A Customized Approach

Download in electronic PDF format for $25



Search the Complete Journal Archives

Sevelamer Suspension in Children with End-Stage Renal Disease

Author(s):  McElhiney Linda F

Issue:  Jan/Feb 2007 - Pediatric Patients
View All Articles in Issue

Abstract:  Control of hyperphosphatemia is a major clinical challenge in children with end-stage renal disease. The best treatment option is a calcium-based phosphate binder, but there is evidence that this treatment protocol causes long-term complications, including vascular calcifications. Sevelamer hydrochloride has been shown to be effective in reducing serum phosphorus levels and the calcium-phosphorus ion product in children on maintenance dialysis and may be key in preventing soft-tissue and vascular calcifications in such patients. Until the U.S. Food and Drug Administration approves the use of sevelamer hydrochloride in children undergoing dialysis, and a liquid dosage form becomes available, compounding pharmacists will need to prepare this unique compound for these patients.

Related Keywords: CHILDREN, INFANTS, CHRONIC RENAL FAILURE, KIDNEY FAILURE, END-STAGE RENAL DISEASE, ESRD, HYPERPHOSPHATEMIA, FIXED OIL, RENAGEL, DIALYSIS, PHOSPHORUS, PHOSPHATE BINDERS, SEVELAMER HYDROCHLORIDE, ORAL SUSPENSION, LIQUID PREPARATIONS, DOSAGE FORMS, FORMULATI

Related Categories: FORMULATIONS, NUTRITION AND NUTRICEUTICALS, PEDIATRICS, STABILITIES, COMPATIBILITIES, UROLOGY/URINARY TRACT

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Sevelamer Suspension in Children with End-Stage Renal Disease McElhiney Linda F Jan/Feb 2007 20-24 Buy
Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report McNulty Jack P, Hahn Kristian Sep/Oct 2012 364-368 Buy
Conservative Management of Chronic Kidney Disease in Cats: Recommendations for Veterinarians and Compounding Pharmacists Meadows Richard L, Muller George Sep/Oct 2010 382-394 Buy
Basics of Compounding for Raynaud's Disease Glasnapp Andrew Jul/Aug 2003 288 Buy
Stability of Oral Liquid Dosage Forms of Ethacrynic Acid Gupta Vishnu D, Ling Jie May/Jun 2001 232-233 Buy
Pediatric Compounding: Coloring Outside the Lines Preckshot John Jan/Feb 2001 6 Buy
Treating Canine Hepatic Disease Davidson Gigi S May/Jun 2003 188 Buy
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Nahata Milap C May/Jun 2016 247-249 Buy
The Treatment of Canine Atopic Disease Davidson Gigi S May/Jun 2002 210-215 Buy
Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms Gupta Vishnu D Sep/Oct 2009 445-446 Buy